Imaging AI platform company HOPPR secured nearly $32 million in Series A funding to advance its infrastructure for building and deploying large-scale medical imaging AI models.
Key Details
- 1HOPPR, founded in 2019 and based in Chicago, focuses on AI infrastructure for medical imaging.
- 2The company announced nearly $32 million in Series A funding, led by Greycroft and Kivu Ventures.
- 3Its platform supports PACS vendors and software makers in developing clinical-grade AI applications.
- 4The new funds will accelerate platform development, expand foundation model capabilities, and grow the team.
- 5CEO Khan Siddiqui, MD, states the goal is to democratize access to high-performing, trustworthy imaging AI.
Why It Matters
This funding round enables HOPPR to scale its infrastructure, potentially accelerating the development and deployment of clinically robust AI tools in radiology. Broad access to such platforms could enhance diagnostic workflows, support radiologists, and improve patient care globally.
Source
Radiology Business
Related News
•Radiology Business
MRI AI for Parkinsonian Syndrome Gains FDA De Novo Clearance
Neuropacs Corp.'s MRI AI software earns FDA De Novo classification to assist in Parkinsonian syndrome diagnosis.
•Radiology Business
Lucida Medical Raises $11M for AI-Based Prostate MRI Diagnosis Expansion
Lucida Medical, specializing in AI-assisted prostate cancer diagnosis via MRI, raises $11.4M to drive US FDA approval and platform expansion.
•Radiology Business
Radiologists Push Back Against AI CEO's Claims of Specialty Replacement
Radiologists challenge Anthropic CEO Dario Amodei's assertion that AI has already replaced their core tasks.